top of page

Wed, 07 Dec

|

Christmas Market Sechseläutenplatz

SMPA Local Meeting: Zurich

Join us for a cup of Glühwein at the Christmas market!

Registration is closed
See other events
SMPA Local Meeting: Zurich
SMPA Local Meeting: Zurich

Time & Location

07 Dec 2022, 18:30

Christmas Market Sechseläutenplatz, Sechseläutenplatz, 8001 Zürich, Switzerland

About the event

The most wonderful time of the year calls for another meeting in Zurich! Join us for a cup of mulled wine at the beautiful Christmas market at Sechseläutenplatz. 

Meeting point: 6.30pm at the entrance to Orell Füssli Bellevue (https://goo.gl/maps/1CbcfA1rBhknuh5x7)

*****

Local meetings are informal networking events. Use this great opportunity to meet your colleagues at various stages of their scientific career, and to learn more about the SMPA and what it can do for you!

SMPA Zurich special: free drink for our followers on Twitter or LinkedIn!

For questions and comments, contact us at info@swiss-mdphd.com.

Hosts: Irma Telarovic & Lucie Bourguignon

Share this event

Event Info: Events

MEET THE KEYNOTE SPEAKERS

Event Info: Our Team
MadihaDerouazi_edited_edited_edited.jpg

MADIHA DEROUAZI

CEO Speransa Therapeutics


Topic: “From research to the vaccine vials”

Madiha has been working on vector engineering and vaccine design for over 17 years. She has a strong background in applied molecular and cellular biotechnology, in virology and in immunology, with research interests at the interface of fundamental and translational research, the so-called bench-to-bedside. She especially focuses on immune stimulation and immune modulation, both in the oncology and infectious disease fields.


Madiha holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.

Madiha is also the Scientific Founder of AMAL Therapeutics, a Swiss biotech company developing first-in-class therapeutic cancer vaccines. She designed and characterized a CPP-based multi-epitopic cancer vaccine in the Laboratory of Tumour Immunology of the University of Geneva, which is the basis of the KISIMA proprietary vaccine platform. Madiha excitingly drove the integration of AMAL Therapeutics into the Boehringer Ingelheim.

SPONSORS

SMPA Conference 2023 has been made possible thanks to the generous support of:

Event Info: Text

PLATINUM SPONSORS

DBM

DEPARTMENT OF BIOMEDICINE BASEL / UNIVERSITY OF BASEL MD-PHD PROGRAM

SAMW

SWISS ACADEMY OF MEDICAL SCIENCES

Event Info: Clients

PREMIUM SPONSORS

UniGe

UNIVERSITY OF GENEVA, FACULTY OF MEDICINE

KFS

SWISS CANCER RESEARCH / SWISS CANCER LEAGUE

FMH

FMH SWISS MEDICAL ASSOCIATION

Event Info: Clients

OTHER SPONSORS

AlumniMedizin

ALUMNI MEDIZIN BASEL

UniBe

UNIVERSITY OF BERN, MD-PHD PROGRAM

UZH

UNIVERSITY OF ZURICH, CLINICAL SCIENCE PHD PROGRAM

Event Info: Clients
SSAI
Microsynth
Swissheart
Rheumatologie
USB
Interessenverband
UNIL
Event Info: Clients
bottom of page